Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.65, demonstrating a -4.12% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.26%.

EL PASO, Texas (KTSM) — Artists from the Youth Opera of El Paso appeared on “Second Cup” with Mike and Tricia on Friday morning, Jan. 9. The EPYO will be performing “A Note of Explanation” at 7:30 p.m ...

Abstract: This paper studies the control-oriented recursive identification of finite impulse response systems with binary-valued observations. Inspired by the Maximum Likelihood method, a novel ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

The Los Angeles Dodgers won Game 1 of the NLCS, 2-1, taking home-field advantage from the Milwaukee Brewers. It was a close game the whole way, with the Dodgers' offense struggling to get going.

This post is part one of a series. Attention is a multifaceted process that manages the mental controls needed for school or work. Filtering incoming information to determine its importance (saliency) ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Recursion Pharma is an AI-driven drug developer that boasts supercomputers designed to shorten drug development timelines and enhance successful outcomes. Many such companies have raised substantial ...